FOAMS
We propose a wide range of foams ensuring that the user has the best solution for his risk.
The 3F basics
The answer to replace these chemical components lies in the combination of surfactants and polymers on a natural basis and the synergistic combination of their properties allowing a complete range of foams to be used.
We propose a wide range of foams ensuring that the user has the best solution for his risk.
We provide equipment to apply foam onto the fire in the safest, most efficient and economical manner.
DOSING SYSTEM
Electronic Dosing Systems Mechanical Dosing SystemsOther equipment
Fire Disaster PreventionAn environmentally friendly complete solution that, beyond overall performance and efficiency, will eliminate the environmental damage caused by foams.
Our environmental charter
Environment3F is committed to the path of fluorine-free products with its class A additives and class B multi-purpose foams. 3F innovates and launches its SMART FOAM -SF range of solvent-free foams as a preview on the market.
Discover the SMART FOAM rangeA global network
3F is a company run by experienced people who have demonstrated their knowledge in firefighting over the last thirty years. With offices in England, Singapore and Panama, our company is able to respond quickly and efficiently to the demands of our customers all over the world.
Togo
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Benin
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Niger
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Mauritania
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Mali
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Burkina Faso
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Madagascar
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Angola
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
New Caledonia
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Luxembourg
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Belgium
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Croatia
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Hungary
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Romania
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
New Zealand
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Salvador
3F AMERICAS Inc.
Xiomara Escalante
ventas@3famericas.com
+507 6494 5421
Belize
3F AMERICAS Inc.
Xiomara Escalante
ventas@3famericas.com
+507 6494 5421
Canada
3F AMERICAS Inc.
Thierry Bluteau
export@3famericas.com
+33 761 461 665
United Arab Emirates
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Cuba
3F AMERICAS Inc.
Xiomara Escalante
ventas@3famericas.com
+507 6494 5421
Honduras
3F AMERICAS Inc.
Xiomara Escalante
ventas@3famericas.com
+507 6494 5421
Nicaragua
3F AMERICAS Inc.
Xiomara Escalante
ventas@3famericas.com
+507 6494 5421
Dominican Republic
3F AMERICAS Inc.
Xiomara Escalante
ventas@3famericas.com
+507 6494 5421
Costa Rica
3F AMERICAS Inc.
Xiomara Escalante
ventas@3famericas.com
+507 6494 5421
Guatemala
3F AMERICAS Inc.
Xiomara Escalante
ventas@3famericas.com
+507 6494 5421
Mexico
3F AMERICAS Inc.
Armando Merino
amerino@3famericas.com
+52 442 336 0675
Bolivia
3F AMERICAS Inc.
Pablo Rojas
projas@3famericas.com
+593 99 99 600 92
Colombia
3F AMERICAS Inc.
Pablo Rojas
projas@3famericas.com
+593 99 99 600 92
Peru
3F AMERICAS Inc.
Pablo Rojas
projas@3famericas.com
+593 99 99 600 92
Ecuador
3F AMERICAS Inc.
Pablo Rojas
projas@3famericas.com
+593 99 99 600 92
Chile
3F AMERICAS Inc.
Pablo Rojas
projas@3famericas.com
+593 99 99 600 92
Panama
3F AMERICAS Inc.
Thierry Bluteau
export@3famericas.com
+33 761 461 665
Argentina
Melisam Fire Group
Melisam Fire Group
info@melisam.com
5411 4766-6100
Uruguay
3F AMERICAS Inc.
Thierry Bluteau
export@3famericas.com
+33 761 461 665
Venezuela
3F AMERICAS Inc.
Thierry Bluteau
export@3famericas.com
+33 761 461 665
Brazil
3F AMERICAS Inc.
Thierry Bluteau
export@3famericas.com
+33 761 461 665
Australia
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Oman
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Iraq
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
India
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
China
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Pakistan
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
South Korea
3F ASIA
Kenneth Loh
kenneth@3fffasia.com
+65 9738 3218
Japan
3F ASIA
Kenneth Loh
kenneth@3fffasia.com
+65 9738 3218
Brunei
3F ASIA
Kenneth Loh
kenneth@3fffasia.com
+65 9738 3218
Laos
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Cambodia
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Taiwan
3F ASIA
Kenneth Loh
kenneth@3fffasia.com
+65 9738 3218
Philippines
3F ASIA
Kenneth Loh
kenneth@3fffasia.com
+65 9738 3218
Thailand
3F ASIA
Kenneth Loh
kenneth@3fffasia.com
+65 9738 3218
Vietnam
3F ASIA
Kenneth Loh
kenneth@3fffasia.com
+65 9738 3218
Indonesia
3F ASIA
Kenneth Loh
kenneth@3fffasia.com
+65 9738 3218
Malaysia
3F ASIA
Kenneth Loh
kenneth@3fffasia.com
+65 9738 3218
Singapore
3F ASIA
Kenneth Loh
kenneth@3fffasia.com
+65 9738 3218
Sudan
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Egypt
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Kenya
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
South Africa
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Mauritius
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Congo BZ
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Gabon
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Ghana
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Cameroun
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Ivory Coast
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Senegal
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Libya
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Tunisia
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Algeria
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Morocco
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Italy
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Switzerland
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Portugal
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Spain
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
France
3FFF Ltd
Thierry Bluteau
export@3fff.co.uk
+33 761 461 665
Malta
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Cyprus
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Turkey
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Greece
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Netherlands
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Austria
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Germany
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Poland
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Lithuania
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Latvia
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Estonia
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Finland
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Sweden
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Norway
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Denmark
3FFF Ltd
Gary McDowall
sales@3fff.co.uk
+44 1536 202 919 / +44 7801 850 011
Ireland
ABC McIntosh Ltd
Becky McDowall
becky@abcmacintosh.com
+44 1536 260 333
United Kingdom
ABC McIntosh Ltd
Becky McDowall
becky@abcmacintosh.com
+44 1536 260 333
Previous articles (Parts 1 to 4) have dealt with the history, chemistry, environmental and health impacts of PFAS exposure.
Regulators have become increasingly aware of the risks implied by the manufacture and use of perfluorinated compounds in industrial and consumer products and, as a result, many countries have enacted legislation restricting the use and disposal of PFAS.
Lack of knowledge of best available practice (BAP) or the law is no defence when it comes to defending one’s actions that may have led to environmental contamination, as encapsulated in the legal phrase “ignorantia legis neminem excusat (“ignorance of law excuses no one”)”. This doctrine first shows up in the Bible in Leviticus 5:17: “If a person sins and does what is forbidden in any of the Lord’s commands, even though he does not know it, he is guilty and will be held responsible.”
A modern interpretation of this principle has been established under the Rio Convention in 1992 as the precautionary principle under which lack of evidence must not be treated as evidence of lack of harm, especially where long term intergenerational effects may be suspected.
Shortly after the announcement by the 3M Company in May 2000 that they were withdrawing from PFOS-based chemistry, RAK and his colleagues arranged a series of international conferences in Manchester and Bolton to discuss environmental issues associated with firefighting foams. These Reebok seminars which took place in 2002, 2004, 2007, 2009 and 2013, were well attended by the fluorochemical industry, regulators, foam manufacturers and end-users such as fire departments worldwide. These seminars became the de facto industry forum for discussing the phase out of Class B AFFF and the transition to Class B fluorine-free foams (F3).
At the earliest Reebok seminar in 2002 it was pointed out that the U.K. GroundWater Regulations 1998 already prohibited the discharge of fluorochemicals as found in AFFF foams to groundwater if they were PBT – Persistent, Bio-accumulative and Toxic. Unfortunately given clear lack of knowledge of the significance of the term ‘organohalogen’ of the regulation (SI 2746/1998) it was claimed that this was not relevant.
Later Reebok seminars, especially in 2004 and 2007, concentrated not just on PFOS but also on PFOA and related substances that could degrade to PFOA, a typical perfluorinated extremely persistent PFCA end-product of breakdown. The possibility of derivatives such as 8:2FTS, as found in C6/C8 fluorotelomer foams, bio-degrading to yield PFOA was at first vigorously denied by the fluorochemical industry in the face of published evidence suggesting the contrary. However, the whole tenor of the discussion changed as a result of pressure from the US-EPA which resulted in the 2010-2015 PFOA Stewardship Programme leading ultimately to a requirement for fluorotelomer products to contain less than 25 ppb PFOA or its precursors.
i) 1998: Subject to sub-paragraph (2) below, a substance is in list I if it belongs to one of the following families or groups of substances–
(a) organo-halogen compounds and substances which may form such compounds in the aquatic environment;
ii) 2009: This includes in particular the following when they are toxic, persistent and liable to bio-accumulate—
(a) organohalogen compounds and substances which may form such compounds in the aquatic environment;
The German Federal Environment Agency’s (das Umweltbundesamt or UBA) Human Biomonitoring Commission has established trigger levels for both PFOS and PFOA in human blood plasma. The HBM-I value is the plasma concentration in ng/ml (ppb) that is estimated to pose no appreciable risk to the human population for prolonged exposure and, thus,no need for further action. Concentrations between HBM-I and HBM-II indicate that health impacts cannot be excluded with sufficient certainty and that further investigation is necessary with the introduction of measures to eliminate, reduce or control exposure, including identifying potential sources and checking analytical results. Plasma concentrations in excess of HBM-II values, indicating possible health impacts, require immediate intervention to reduce or eliminate exposure and assessment of any health impacts.
The HBM-I and HBM-II values for PFOS and PFOA are shown below. For women of child-bearing age the HBM-II values recommended are half those for the general population. It is worth noting the PFOA values are less than those for PFOS.
The story for firefighters who are or have been occupationally exposed to PFAS-based AFFF is a rather different story. Long service firefighters as well as those more recently employed may have plasma levels far in excess of acceptable values especially for PFOS and its homologue PFHxS, which are correlated. As an example, the figure below shows PFOS plasma levels in 2015-2016 for an extensive cohort of firefighters from a large Australian fire brigade, in which the majority had levels in excess of HBM-II. THE HBM-I level is shown as the yellow vertical line, HBM-II in red. Nearly 2/3 of the sampled cohort exceeded HBM-II indicating a potential health risk.
The major exposure pathway for firefighter exposure to PFAS is clearly the use of AFFF fluorochemical containing firefighting foam either operationally or during training and maintenance. The mechanism of exposure is undoubtedly either the inhalation of foam aerosol especially for those personnel not wearing self-contained breathing apparatus (SCBA), or through dermal absorption as a result of being soaked with foam spray. At any major incident involving foam, for example a fuel tank fire, approximately a third of the foam applied from monitors never reaches the fire itself but is lost as a foam curtain and aerosol which contaminates the surrounding area and any personnel present.
Drinking water is the one unavoidable exposure pathway for everyone. Average intake is calculated as ~2 litres/day over one’s lifetime. Maximum total weekly intakes (TWI) are calculated on this basis.
The revised EU Drinking Water Directive entered force in January 2021, with full compliance by 12 January 2023, and included measures tackling emerging contaminants such as endocrine disruptors and PFAS, as well as microplastics. The maximum concentration of all PFAS compounds combined 0.5 μg per liter of water (500 ppb). Alternatively, member states can monitor the sum of 20 specified PFAS compounds, for which the maximum is 0.1 μg/l (100 ppb).
The Netherlands National Institute for Public Health and the Environment (RVIM) has recently derived new limits risk limits for PFAS in surface waters [*2022-0074 RVIM 2022-09-08] based on EFSA derived health-based values for PFAS in 2020. The new risk limits are 0.3 ng/l (0.3 ppt) for PFOA, 7 pg/l (0.007 ppt) for PFOS), and 10 ng/l (10 ppt) for Gen-X. These are much lower than current standards for these PFAS.
The limits on PFAS in selected food products on the EU market are listed in Table 1. If higher concentrations are discovered in laboratory tests, the product has to be removed from the market.
The Intergovernmental Forum on Chemical Safety (IFCS) and the International Programme on Chemical Safety (IPCS) prepared an assessment of the 12 worst offenders, known as the dirty dozen, as the initial POPs listed under the Annexes of the Stockholm Convention. These substances included the pesticides Aldrin, Chlordane, DDT, Dieldrin, Endrin, Heptachlor, Hexachlorobenzene HCB, Mirex, Toxaphene; and the industrial chemicals polychlorinated biphenyls PCB, polychlorinated dibenzo-p-dioxins PCDD and polychlorinated dibenzofurans PCDF.
The INC met five times between June 1998 and December 2000 to elaborate the convention, and delegates adopted the Stockholm Convention on POPs at the Conference of the Plenipotentiaries convened in May 2001 in Stockholm, Sweden. The convention entered into force on 17 May 2004 with ratification by an initial 128 parties and 151 signatories. Co-signatories agreed to outlaw nine of the dirty dozen chemicals.
The first set of new chemicals to be added to the convention were agreed at a conference in Geneva on 8 May 2009.
In 2009, perfluorooctane sulfonic acid and its derivatives -PFOS- have been included in the UN Stockholm Convention to eliminate their use (decision SC-4/17). In 2019, following the evaluation by POPRC-14 in 2018 at FAO Headquarters in Rome of the continued need for PFOS, its salts and PFOSF, COP9 amended Annex B to remove several of the specific exemptions and acceptable purposes for PFOS, its salts and PFOSF (decision SC-9/4).
• UNEP/POPS/POPRC.2/17/Add.5: Risk profile for perfluorooctane sulfonate
• UNEP/POPS/POPRC.3/20/Add.5: Risk management evaluation for perfluorooctane sulfonate
• UNEP/POPS/POPRC.4/15/Add.6: Addendum to the risk management evaluation for perfluorooctane sulfonate
In 2019, COP9 listed PFOA and its derivates in Annex A to the Stockholm Convention (decision SC-9/12). POPRC Secretariat developed an indicative list of substances, originally containing around 4,700 compounds; the list is to be updated periodically. PFOA has been banned under the POPs Regulation since 4 July 2020.
• UNEP/POPS/POPRC.12/11/Add.2: Risk profile for PFOA, its salts and PFOA-related compounds
• UNEP/POPS/POPRC.12/INF/5: Additional information relating to the risk profile for PFOA, its salts and PFOA-related compounds
• UNEP/POPS/POPRC.13/7/Add.2: Risk management evaluation on PFOA, its salts and PFOA-related compounds
• UNEP/POPS/POPRC.14/6/Add.2: Addendum to the risk management evaluation on PFOA, its salts and PFOA-related compounds
• UNEP/POPS/POPRC.17/INF/14/Rev.1: Updated indicative list of substances covered by the listing of PFOA, its salts and PFOA-related compounds
In June 2022, the UN Stockholm Convention also decided to include PFHxS and related compounds in the treaty. The Commission added the substance group in the EU’s POPs Regulation in May 2023 and the regulation entered into force on 28 August 2023.
The POPRC is currently reviewing LongChain-PFCAs, and related compounds, proposed for listing in Annexes to the Stockholm Convention.
• UNEP/POPS/POPRC.17/7: Proposal to list long-chain perfluorocarboxylic acids, their salts and related compounds in Annexes A, B and/or C to the Stockholm Convention on Persistent Organic Pollutants
White Papers from IPEN PFAS Expert Panel 2018-2019
Three influential White Papers produced by the IPEN PFAS Expert Panel in 2018-2019, coordinated by Roger Klein and colleagues, were presented to the UN Stockholm Convention’s POPRC14 in 2018, COP9 and POPRC15 in 2019 discussing progress in transitioning from AFFF to F3 firefighting foams, issues associated with PFAS and PFHxS. These White Papers assisted the Committee in achieving the listing of these PFAS under the appropriate Annexes for restriction or banning in 2019 and 2022.
As of September 2022, there are 186 parties to the UN Stockholm Convention (185 states and the European Union). Notable non-ratifying states include the United States, Israel, and Malaysia.
The first product to be regulated has been PFOS.
Norway prohibited the use of PFOS-containing materials in 2007.
The European Union Commission Regulation (No. 757/2010) required that all foam containing PFOS above 10 mg/kg (0.001% w/w or 10 ppm) must not be used after 27 June 2011 and this was adopted by the UK Environment Agency in February 2011.
In January 2014, the Environmental Agency of Norway has published the Regulation FOR-2013-05-27-550, which bans the use of PerfluroOctanoic Acid -PFOA- and its salts and esters.
Limits were implemented on July 1, 2014 to all products manufactured, imported, exported and marketed in Norway, with the exception of some specific articles for which the new rules were applied in January 1, 2016.
In 2020, EU 2020/784 regulates the use of PFOA and limits the content to 25ppb. In theory, it can be used until 2025 if all effluents can be contained, which is impossible to guarantee. In the facts, the regulation eliminates PFOA in Europe.
Long Chain Perfluorinated carboxylic acids (C9-14 PFCAs), their salts and precursors are restricted in the EU/EEA – EU Regulation 2021/1297 -from February 2023 onwards.
Germany – supported by Sweden, Netherlands, Denmark and Norway – has proposed a further restriction for PerFluoroHexanoic Acid C6 -PFHxA-, its salts and related substances. This proposal is highly significant as it would effectively ban the use of C6-fluorotelomer AFFF foams. This proposal was evaluated by ECHA in December 2021.
The European Chemical Agency -ECHA- is evaluating a global restriction on an EU-wide PFAS ban on firefighting foams. The restriction could reduce PFAS emissions into the environment by around 13 200 tons over 30 years [*June 2023 ECHA/NR/23/19]. An answer is expected to be given in January 2024.
Until recently, there has not been a Federal approach to regulate the use of AFFF in Australia; but each sate had its own way to restrict the use of fluorinated foams.
Canberra – Federal – published in May 2020 NEMP 2.0 to establish a practical basis for nationally consistent environmental guidance and standards for managing PFAS contamination. A draft of PFAS in NEMP 3.0 was released in September 2022.
Queensland Fire Service is using F3 foam since 2003
Queensland Environment Authorities controls PFAS content of AFFF products and banned PFOS.
Fire Services had been using 3M’s foams; and stopped their use in 2007. The Protection of the Environment Operations Regulation 2022 bans and restricts the use of PFAS firefighting foam in NSW to reduce its impact on the environment, while still allowing its use for preventing or fighting catastrophic fires by relevant authorities and exempt entities. The Regulation aligns with the National PFAS Position Statement and is the first step to achieving the agreed objectives in the Statement.
In 2007, Victoria Fire Service – MFB- made a decision to replace existing firefighting foam with fluorine-free firefighting foam. This decision was made on the basis of concerns relating to firefighter health and environmental issues. MFB developed an ‘Operational Use of Firefighting Foam Policy’ which was formally endorsed by the Environmental Protection Authority (EPA), WorkSafe and the Country Fire Authority (CFA). During 2011, based on independent scientific studies into PFAS, that identified links to various cancers and other health concerns, MFB extensively trialled and Fire Rescue Victoria evaluated various fluorine-free firefighting foam in hot fire, flammable liquid, B Class fire scenarios. MFB found that the fluorine-free foam consistently performed well in extinguishing B Class fires and provided MFB firefighters with a proven ‘safer’ alternative extinguishing medium. This work provided MFB with an operational firefighting foam solution that could be effectively used at Department of Defence sites, such as RAAF Airbases at Point Cook and Laverton. This enables MFB and FRV to meet its obligations for the delivery of emergency services to Defence bases using firefighting foam that does not contain PFAS. By 2014, all MFB firefighting appliances had been converted to only carry fluorine free B Class foam in their foam tanks.
A ban on fluorinated foams came into effect in South Australia in January 2018, but licensees have the opportunity to apply for an exemption in certain circumstances.
Outlined work has been undertaken to identify and manage PFAS in December 2017; but now following Federal NEMP.
TasPorts is a leader in Tasmania’s approach to managing PFAS and fully eliminated all PFAS-containing foams from the island.
Since 2010, Airservices has carried PFAS-free fire fighting foam at all civilian airports where it operates.
New Zealand excluded PFOS and PFOA from use in any solid or liquid substances that are imported or manufactured for use as a firefighting chemical in the Fire Fighting Chemicals Group Standard 2006 under the NZ Hazardous Substances and New Organisms Act 1996.
Firefighting foam soil and water contamination has been reviewed in December 2020. Total ban of PFAS in firefighting foams will apply from December 2025.
Food Standards Australia & New Zealand (FSANZ) launched a monitoring of Perfluorinated Chemicals in Food since April 2017, with Health guidance for Daily Intake Dosis values for PFOS, PFOA and PFHxS.
Canada has always been at the forefront of awareness and regulation as regards the inherent and potential risks of releasing PFAS to the environment and exposing the human population to PFAS contamination through drinking water, agricultural products and domestic use.
The Government of Canada is considering activities that would address PFAS as a class rather than as individual substances or in smaller groups. Addressing PFAS as a class of chemicals would reduce the chance of regrettable substitution, support more holistic research and monitoring programs, and provide an opportunity for a decrease of future environmental and human exposure to PFAS. A notice of intent to address the broad class of PFAS was published in the Canada Gazette, Part I: Vol. 155 No. 17 – April 24, 2021.
In response to the commitment described in the notice of intent the Government of Canada has published a Draft State of Per- and polyfluoroalkyl substances (PFAS) Report for a 60-day public comment. The related notice was published in the Canada Gazette, Part I: Vol. 157, No. 20 – May 20, 2023.
Currently, only a limited number of PFAS subgroups are subject to regulation in Canada. PFOS, PFOA, LC-PFCAs and related derivates have been assessed and added to the List of Toxic Substances under Schedule 1 of the Canadian Environmental Protection Act, 1999 (CEPA).
Since 2016, the manufacture, use, sale, offer for sale or import of PFOS, PFOA, LC-PFCAs, and products that contain them have been prohibited, with a limited number of exemptions under the Prohibition of Certain Toxic Substances Regulations, 2012. In May 2022, the federal government published a proposed new Prohibition of Certain Toxic Substances Regulations, 2022, which would replace the Prohibition of Certain Toxic Substances Regulations, 2012 and eliminate most exemptions allowing the use, sale, or import of PFOS, PFOA and LC-PFCAs in Canada.
Canada prohibited the use of foam containing PFOS above 0.5 ppm in May 2013, the regulation came into force in May 2008.
In 2004, it was estimated that there was approximately 45 million liters of AFFF concentrate in the United States and its territories.
The National Defense Authorization Act passed by Congress in late 2019, required the US Navy to publish a new military specification for a fluorine-free foam by the end of January 2023 and required a full transition to fluorine-free firefighting foams by October 2024. Congress had imposed earlier mandates on the FAA to transition airports to fluorine-free foams by October 2021, but that deadline was missed. The new MIL-SPEC regulations pave the way for both FAA airports and military bases to transition, requiring significant investment. According to a 2021 Congressional report, the Military and Civilian airports still have about ~50 million litres of AFFF concentrate at its facilities. Although the military has yet to officially approve a f1uorine-free foam for use at its facilities, there now exist a number of commercially available products that have passed appropriate performance tests such as UL.
In the USA, every state has been going its separate way. The scandal of withheld fluorochemical toxicity and environmental impact information as well as outright misinformation, emerged from a long series of judicial court cases against PFAS feedstock manufacturers. The story even culminated in the publication of advertisements from attorneys looking for customers to go to court!
State governments are taking legislative and regulatory actions to phase out PFAS in products to prevent contamination in favour of safer alternatives. For example, laws in ME and WA have given state agencies authority to ban PFAS in a wide range of products. Maine’s law requires product manufacturers to disclose the presence of PFAS. Several states have adopted restrictions on PFAS in textiles with CA banning PFAS in almost all textiles by 2025, and NY restricting them in apparel, CO banning them in upholstered furniture, and WA moving forward on regulatory actions on many categories of textile products. Six states (CA, CO, ME, MD, NY, and VT) have adopted restrictions on PFAS in carpets, rugs and after-market textile treatments. Twelve states (CA, CO, CT, HI, MD, ME, MN, NY, OR, RI, VT, and WA) have enacted state bans on PFAS in food packaging. Four states (CA, CO, MD, and WA) have adopted restrictions on PFAS in personal care products. CO also adopted restrictions on oil and gas products. Eleven states including CA, CO, CT, HI, IL, ME, MD, NH, NY, VT, and WA have put in place bans on the sale of firefighting foam containing PFAS. With legislation adopted last year, WA is evaluating safer alternatives for PFAS in other products such as apparel, cleaners, coatings and floor finishes, firefighter turnout gear and others with a timeline of adopting restrictions by 2025. Source www.saferstates.org
Due to the judicial court cases, most of the national manufacturers ceased the production of AFFF foam in 2024 and started to promote fluorine-free foams, not only in the USA, but to all their traditional markets and customers.
This is huge and potentially extremely expensive problem. At major incidents such as Milford Haven (August 1983), Sandoz Basel (November 1986), Coode Island (Melbourne August 1991), , Buncefield (December 2005) or Campbellfield (Melbourne April 2019), tens of millions of liters of foam-contaminated firewater run-off were released to the environment – total containment at such large incidents is almost impossible and any waste that is collected must be disposed of appropriately. Legacy stocks of fluorinated foam concentrates represent a large financial expenditure as part of transitioning to fluorine-free products, as does the decontamination of fixed and mobile equipment.
Currently the most effective, financially feasible and environmentally sustainable method for disposing of large quantities of PFAS contaminated solid or liquid waste appears to be very high temperature incineration. Costs can range between 1000-3000 USD, strongly depending on the accepted level of residual fluorinated contaminant.
Evermore regulations, especially in Europe and Australia/New Zealand, are targeting especially dispersive applications using PFAS such as firefighting foams. The transition from AFFF to fluorine-free foams -F3- has become possible, given rapid technological advances in the last 5-10 years and fluorine-free products able to compete with AFFF based on performance.
Many large organizations such as civilian and military airfields, as well as Oil& Gas, Chemical, Mechanical industry such as Equinor, Bayer, Lufthansa and BMW, have already gone fluorine-free, having solved the problems of old AFFF equipment and appliance decontamination as well as compatibility in terms of delivery systems and operational training.
Most recently, we have seen some awareness growing in Environment Regulation Bodies – Singapore, Mexico, Colombia – showing a deep interest in what has been happening in other countries; it is likely that the ban on ‘’Forever chemicals’’ will be extended to the world community in the next 5 to 10 years !
Krogerus, M. (2012) The Decision Book: Fifty Models for Strategic Thinking. Tschäppeler, R. and Piening, J. (1st American edition), New York, W.W. Norton & Co., pp. 86-87.
Rumsfeld, D. (2002)
Rio Convention (1992)
United States (1933) Securities Act.
Preston, B.J. (2017) The Judicial Development of the Precautionary Principle. Queensland Government Environmental Management of Firefighting Foam Policy Implementation Seminar 21 February 2017, Brisbane, Qld., pp. 26.
Preston, B.J. (2018) ‘The Judicial Development of the Precautionary Principle’ Environmental and Planning Law Journal 135, 23-42.
Allcorn, M., T. Bluteau, J. Corfield, G. Day, M. Cornelsen, N.J.C. Holmes, R.A. Klein, J.G. McDowall, K.T. Olsen, N. Ramsden, I. Ross, T.H. Schaefer, R. Weber, K. Whitehead. (2018) “Fluorine-Free Firefighting Foams (3F) Viable Alternatives to Fluorinated Aqueous Film-Forming Foams (AFFF).” UN Stockholm Convention POPRC14 Rome 17-21 September 2018, IPEN Gothenburg Sweden: IPEN F3 Expert Panel. < www.ipen.org >
Bluteau, T., M. Cornelsen, G. Day, N.J.C. Holmes, R.A. Klein, J.G. McDowall, K.T. Olsen, M. Tisbury, and L. Ystanes. (2019) “The global pfas problem: fluorine-free alternatives as solutions firefighting foams and other sources-going fluorine-free.” UN Stockhom Convention COP9 Geneva Apr-May 2019, IPEN Gothenburg Sweden: IPEN F3 Expert Panel. < www.ipen.org >
Bluteau, T., M. Cornelsen, N.J.C. Holmes, R.A. Klein, M. Tisbury, and K. Whitehead. (2019) “Perfluorohexane sulfonate (pfhxs)-socio-economic impact, exposure, and the precautionary principle.” UN Stockholm Convention POPRC15 Rome Sep-Oct 2019, IPEN Gothenburg Sweden: IPEN F3 Expert Panel.
< www.ipen.org >
3F AMERICAS will start to promote and distribute an innovative set of new products through its network of distributors in Latino America. These new products are a revolution in the field of protection of personal firefighting firemen.
One set of equipment is a luminous light line which works 2-Way. The line is highly resistant to heat, to stress and is offered in 3 versions: a personal line 25 meters, a portable line 50 meters, and a waterproof line 25 meters for underwater operations.
The other equipment is a lifesaving personal alarm. It offers several UNIQUE benefits.
It works under 6 different modes, set a visual and audible – 98 dB – alarm for an exposure to heat, impacts, movement . It is water-protected IP68 and the battery stands up to 20 hours and can be charged directly on its charging cradle. It is the lightest tool on the market and weighs only 120 g. See more …..
As detailed previously in first three parts of this series of articles, we have seen that the perfluorochemicals have a long history spanning more than 50 years and are far more complex than just considering PFOS, PFHxS and PFOA. Rather there are literally thousands of perfluorochemicals used in industry and commerce and focusing solely on a few named structures is unhelpful and a form of ‘tunnel vision’.
Currently there have been strong arguments put forward to treat PFAS as a class of chemical compounds, rather than as individual compounds each requiring the assessment of risk [Kwiatkowski et al (2020)], as a means of countering the disadvantages of concentrating on a few named PFAS. In seeking to regulate PFAS use the concept of ‘essential uses’ has been proposed by the Cousins group [Roy et al. (2022); Figuiére et al. (2023)].
Independent academic and regulatory interest in this class of compounds was virtually non-existent, with some notable exceptions, until the 3M Company announced in May 2000 that it was phasing-out all PFOS-based chemistry replacing it with PFBS chemistry (perfluorobutane sulfonic acid, the C4 homologue of PFOS). A notable exception which was highly relevant to understanding environmental contamination caused by AFFF foams was work published by Jennifer Field and her colleagues at Oregon State University around the same time or shortly after 3M announced its withdrawal from PFOS chemistry and foam manufacture [Moody et al. (2000); Schultz et al. (2004)].
Investigative activity concerning this class of compounds started shortly after the 3M announcement in May 2000. At first most of the contributions were from the industry itself or from groups funded by the industry. It was in the late 2000s that the independent scientific community realized that there were far more that needed investigating about the impact of PFAS both on human health and the environment, with the result that the number of peer-reviewed publications increased exponentially..
Publications concerned with PFAS in the run-up to May 2000 were only in the range of 5-10 per year. After May 2000 these increased to around 50 per year and have increased exponentially since now reaching ~1000/year, frequently associated with a parallel increase in articles on microplastics [Bakhshoodeh and Santos (2022)], from whom Figure 2(b) is taken.
Published studies on the scale of environmental by PFOS and PFOA were scarce before 2001, until Giesy and Kannan [Giesy and Kannan (2001) and subsequent papers] reported global presence of PFOS in wildlife, with Hansen et al. finding PFOS and PFOA downstream from a manufacturing facility on the Tennessee River [Hansen et al. (2002)], as well as in biological matrices using mass spectrometry [(Hansen et al. (2001)].
Although contamination of human blood samples with organofluorine chemicals not present in stored blood taken before fluorochemical manufacturing began had been reported some years earlier since the 1960s [Taves, D.R. (1966, 1968)] with Guy et al. (1976) reporting the presence of fluorochemicals in human plasma using NMR spectroscopy, tentatively identifying PFOA as the fluorochemical used in Scotchgard® as blood contaminant [Guy, W.S. et al. (1976)]. Although there was initial confusion whether this fluorochemical was indeed PFOA or PFOS, as a result of obfuscation and a refusal to identify PFOS by 3M, it was not until 25 years later that Hansen et al. (2001) reported that samples of human plasma contained PFOS (average 28.4 ng/ml), PFHxS (average 6.6 ng/ml) and PFOA (average 6.4 ng/ml), confirming Guy and Taves findings.
A lawsuit filed in 2010 by the Attorney General of the State of Minnesota against the 3M Company revealed that the company knew these chemicals were accumulated in human blood for more than 40 years and were toxic [Lerner (2018); Swanson (2019)].
Until about 2004 the scientific literature was dominated by papers from authors working directly for 3M or funded by the industry. Post 2004 there has been an exponential explosion of independent published work concerned with PFOS, PFOA and other PFAS, to the extent that these organofluorine compounds have been labelled ‘emerging contaminants’. PFAS have emerged as contaminants of concern for at least a decade. The current situation is that although we now know a considerable amount about the environmental distribution, fate and toxicity to biota of PFAS, it is the technology for the remediation and disposal of these highly persistent materials that should be regarded as ‘emerging science’.
As said before, we are not only talking of a few substances, but about a whole family of at least 6000 different perfluorocompounds which have been classified for at least one environmental, human health and/or physicochemical endpoint in the ECHA database. At the UN Stockholm Convention Persistent Organic Pollutants Review Committee meeting in Rome (POPRC-14) an indicative list of PFOA-related substances contained 4,700 entries.
Human health endpoints are considered of major importance for long-term exposure: carcinogenicity ©; mutagenicity (M0; reproductive toxicity (R); lactation effects (L) and specific organ toxicity (STOT). 388 PFAS have at least one of these five endpoints, of which 44 are registered in harmonized classification.
With regards to environmental hazards, 1129 PFAS have been registered by self-classification; most of them counting as both (M) mobile and/or very persistent (vP).
Under the EU chemicals legislation (REACH and ECHA) the risks posed by PFAS are classified using the PBT system indicating persistence (P or vP), bio-accumualation (B or vB), and toxicity (T). Recent proposals from the German Federal Environment Agency (UBA) also stress the importance of mobility (M or vM) especially for PFAS in view of their vP and vM properties [Arp et al. (2023)]. Chemicals may also be identified as Substances of Very High Concern (SVHC) under REACH EC1907/2006 if they have serious and often irreversible effects on human health or the environment. A recent example is perfluorononanoic acid or PFNA, a PFAS that is becoming more commonly found as a contaminant. In Europe there has been far more concern with individual components of the PBT classification whereas in the United States persistence on its own with accompanying toxicity is seen as less of a problem.
Persistence
PFAS or their perfluorinated degradation products are among the most chemically and physically stable organic compounds known. Their perfluorinated carbon chains resist environmental and metabolic degradation due to the very stable C-F bonds. For example, tetrafluoromethane, CF4 and the simple perfluorocarbon, has an estimated atmospheric half-life of ~50,000 years with a high global warming potential (GW) [Mühle et al.(2010)].
Commercially available perfluoro compounds are designed to degrade rapidly once released into the environment yielding PFCAs, PFECAs and PFSAs. Unfortunately, this has led in the past to totally spurious and misleading claims made by the industry especially in the United States that these materials are ‘biodegradable’ based on degradation of the non-fluorinated functional group and the OECD rule that a substance if ‘readily biodegradable’ if degradation reaches 60% (OECD 301B, D and F) or 70% (OECD301A and E) within 28 days. This does not mean that the PFAS, for example in firefighting AFFF, is completely biodegradable as the COD method using acid dichromate for the oxidation measurement to give the 100% level totally fails to account for any perfluorinated material present. Regrettably end-users have often assumed or been led to believe by salesmen, and perpetrated as a myth by certain manufacturer [Swanson, 2019], that ‘readily biodegradable’ means total degradation. As pointed out earlier it makes sense, however, to group all PFAS as non-degradable according to their stable degradation end-products.
Breakdown of the precursors often leads to the formation of PFAS intermediates and ultimate degradation products with increased mobility in water and/or air via oxidative chemical and biochemical degradation processes in the environment.
Lifetimes of the PFAS in the environment greatly exceed the criteria for very persistent (vP) substances in Annex XIII to REACH. If PFAS do degrade, they do it so slowly that it is not observable in standard tests. The extreme persistence of PFAS and their continued use leads to sustained exposure and increasing concentrations in all environment compartments. PFASs will remain in the environment for very long time, even if releases are minimized. Increasing or legacy contamination of the environment will increase the likelihood that known and unknown effects will occur on a generational timescale. This should invoke the application of the Precautionary Principle [Rio 1992; Preston, 2017] to any further dispersive use of PFAS.
Scientists pointed out in the Helsingør Statement on PFASs [Scheringer et al., 2014] as well as in the Madrid statement [Blum et al., 2015] that very high persistence on its own presents a problem and have named this the “P-sufficient approach” to regulatory action. Persistence alone justified the regulation of PFAS as a class in California [Balan et al., 2021].
Long range transport potential (LRTP)
PFAS can be transported by air, water and matrices to which they are adsorbed or absorbed, such as dust, sediments, marine aerosols, oceanic currents, atmospheric, migratory animals, or through matrices in which they are included as additive such as microplastics. Because of their remarkable resistance to degradation, this leads to global dispersion of PFAS over long distances from the point of release. It has been estimated, for example, that for volatile PFAS such as fluorotelomer alcohols in the upper atmosphere that global circulation times can be short as 7-10 days. The historical spread through LRTP of PFAS through deposition and contamination in the Arctic is well documented [Wilson et al. (AMAP) Secretariat, 2017].
The Inuit population in the Arctic has been reported as being some of the most contaminated humans on the planet as the PFAS concentrations in their blood is much higher than the average value for the general population. Being so far removed from any industrial source of PFAS, this contamination has been attributed mainly to their diet, which based on fish, polar bear and seal meat, with an impact on the immune response [Sonne et al., 2023].
Thus, PFAS contamination of the environment and biota is not limited geographically just to the source of the pollution but becomes widespread on a global scale due to dispersive use such as in firefighting foams, poor waste disposal techniques or industrial production, compounded by long-range transport in the atmosphere and oceans.
Mobility
It is generally considered that substances with moderate to high solubility in water associated with low adsorption potential have a high mobility in the aqueous environment. Various studies have shown that PFAS have a different behavior depending strongly on carbon chain length and on functionality.
As shown in the figure below shorter chain-length PFAS are associated with higher environmental mobility, water solubility and volatility, as well as lower toxicity and bio-accumulation potential than longer chain-length PFAS. The combination of extreme persistence and high mobility in the aqueous compartment and soils, especially for the shorter chain PFAS such as PFPeS and PFBS, leads to contamination of drinking water aquifers and rivers as well as uptake into the food chain – fish, plants and livestock.
Accumulation in plants
A recent review article on exposure routes, bio-accumulation and toxic effects of PFASs on plants shows that bio-accumulation processes of PFASs in plants highly vary because of the complexity of PFAS chemistry [Li et al., 2022].
Whereas short-chain PFASs typically accumulate in above-ground plant parts such as leaves, long-chain PFASs accumulate in roots and show lower translocation factors to the above-ground plant parts. This is influenced by the higher water solubility, lower molecular size and lower hydrophobicity of the short-chain PFASs. Studies also indicate that the short-chain PFCA are more effectively taken up by plants than the long-chain PFCA [Felizeter et al., 2014; Yoo et al., 2011].
Consumption of plant material, e.g., grains and vegetables either as roots or above ground plant parts such as leaves or stems, function as a source of PFAS for both humans and animals.
Bio-accumulation and Bio-magnification (tropic magnification)
Under REACH, C11-C14 PFCAs and C6-PFSA have been shown to fulfil the vB-criterion and C8-C10-PFCA the B criterion.
Studies with mammalian species show that PFASs are readily absorbed and distributed across various tissues and that some PFAS (particularly the long-chain PFAS) have long half-lives in organisms, especially in humans where half-lives are of the order of years. Studies show that PFAS binding to albumin and transporter proteins efficiently distributes PFASs into different tissues, and enhances passage across both brain and placental barriers, with transfer to neonates via breast milk. Because of their hydrophobic and oleophobic properties PFAS do not follow typical accumulation patterns, like partitioning into adipose tissue, but rather bind and accumulate in protein-rich organs like liver.
PFASs accumulate more in air-breathing organisms as compared to gill breathing- organisms, because unlike the latter, air-breathers cannot readily eliminate PFAS by passive diffusion. Thus, established methods of bio-accumulation testing in aquatic organisms do not function adequately as methodology for PFAS bio-accumulation assessments in air-breathing species such as man, Unfortunately, laboratory bio-accumulation data are very limited for air-breathers.
Short-chain PFASs are more readily excreted by urinary excretion in air-breathing organisms and tend to be less bio-accumulative, while bio-accumulation potential usually increases with perfluoroalkyl chain length. In general, BCFs and BAFs of PFASs with 8 or more carbons increase uniformly with increasing number of carbons in the alkyl chain, with highest bio-accumulation potential seen for compounds with 12 to 14 carbon-chain length.
Due to these properties, many PFASs accumulate in air-breathers, and long- chain PFASs bio-magnify in marine and fresh-water food webs, reaching high levels in top predators including humans and vulnerable species. This increase in contamination seen as one ascends the food chain is known as trophic magnification and is well established for aquatic species and predators that feed off them. It is noted that consequently this may negatively affect the recommendations related to consumption of meat and/or entrails of certain animals. A a top marine predator guillemot eggs are particularly high in PFAS.Field studies on long- and short-chain PFASs that can be analytically distinguished demonstrate that PFAS
(primarily PFBA, PFBS, PFHpA, PFHxA, PFHxS, PFOS, FOSA, 6:2 FTOH, F-53B, 6:2 Cl-PFESA, TFA, and C9-C11 PFCAs) are found globally throughout the environment in mammals, birds, fish and other vertebrates. In conclusion, and considering the increasing lines of evidence from modelling, laboratory and monitoring studies, there is a justifiable rising level of concern for a subset of PFAS being bio-accumulative while large uncertainties remain for the majority of compounds due to lack of data.
Effects on human health
A vast amount of literature has been published on the health effects of PFAS, especially for PFOA and PFOS. In humans, many perfluoroalkyl acids (PFAA) are readily absorbed by inhalation or ingestion orally, while less is known regarding absorption after dermal exposure. Many PFAA bind to proteins and are thus distributed to protein-rich tissues including liver, kidneys, and blood. Estimated human elimination half-lives for PFAAs range from a few days (PFBA) and months (PFHxA, PFBS) to a few (2-8) years (PFOA, PFNA, PFDA, PFHxS, PFOS), or to >10 years for PFUnDA. Half-lives are much shorter in rodents than in humans and differences in half-lives between sexes is often observed. Consequently, the observed toxicity in rodents underestimates the toxicity to humans. PFAA are mainly excreted via urine and faeces and thus are released to the environment. PFAA have a marked potential for bio-accumulation in humans as shown by the long half-lives and protein-binding.
The European Food Standards Agency (EFSA) extensively reviewed the epidemiological evidence for association between PFAS exposure and adverse effects in humans [EFSA, 2018; EFSA, 2020]. EFSA concluded that increased serum levels of various PFCA and PFSA provoked a reduction in the immune response to vaccination [Grandjean, 2012], increased propensity of infections, increased serum cholesterol, increased serum alanine transferase (ALT) and reduced birth weight. The association with immune effects was considered the most sensitive endpoint in humans (supported by data from experimental animals) and based on this EFSA has established a Tolerable Weekly Intake (TWI) of 4.4 ng/kg body weight/week for the sum of PFOA, PFOS, PFNA and PFHxS [EFSA, 2020].
Experimental animal studies across different groups of PFAS demonstrate that liver, kidney, thyroid, the immune system, and reproduction are major targets for PFAAs’ toxicity. In rat studies, the most consistent effects included enlarged liver, hepatocellular hypertrophy, increased serum ALT, increased kidney weight, reprotoxicity, effects on the lymph system, and decreased serum thyroid hormone levels. In particular liver effects have been observed for most PFAA for which animal studies are available. For PFOS, PFOA, PFNA, and PFDA and their salts this has resulted in harmonized classifications for carcinogenicity (Carc. 2), reproductive toxicity (Repr. 1B), lactation effects (Lact.) and specific target organ toxicity – repeated exposure (STOT RE 1, except for PFDA).
Cumulative effects of co-occurring PFAS
Many different PFAS co-occur in the environment, drinking water, food, and in human blood. Many PFAS exhibit similar effects, such as effects on the liver, kidney, thyroid, serum lipids, and immune system. Accordingly, an assessment of hazards and risks taking into account such combined exposure would reflect exposure conditions more realistically than single compound assessments.
Due to the immense number of PFAS and the lack of toxicological data for the vast majority of them, a combined assessment for all PFASs is unattainable. It is emphasized at this point that combined exposure to different PFASs affecting the same target organs may result in combined more than additive effects, i.e., synergism, making the exceeding of thresholds or limit values more likely than for assessment for individual substances on their own.
CONCLUSION
PFAS are very Persistent (vP) and many are also very Bioaccumulative (vB). Long-range transport processes (LRTP) results in planetary contamination including remote regions such as the Arctic.
Cousins et al. have recently introduced the concept of having already exceeded the ‘planetary boundary’ indicating that global environmental concentrations for PFAS already exceed tolerable sustainable levels [Cousins et al., 2022]. This should be treated as a warning against continuing use and release of PFAS to the environment, especially from dispersive applications such as AFFF firefighting foam.
The permanent presence of PFAS in human blood indicates the level of continued exposure of the general population. PFAS are present in drinking water and in food stocks. Hundreds of scientific studies have highlighted the long-term toxicity of PFAS, effecting the liver, kidneys, thyroid and immune system. The ubiquitous presence of PFAS in human blood and other species worldwide highlights the dangers associated with continued manufacturing and use in industrial and consumer products of extremely persistent organic pollutants which are totally anthropogenic in origin, not occurring naturally.
This schema summarizes all possibilities for PFAS to contaminate the environment and living beings including humans.
References
Arp, H.P.M., Hale, S.E., Borchers, U., Valkov, V., Wiegand, L., Zahn, D., Neuwald, I., Nödler, K., and Scheurer, M. (2023) A prioritization framework for PMT/vPvM Substances under REACH for registrants, regulators, researchers and the water sector. German Environment Agency (Umweltbundesamt) Report 22/2023 pp. 1-238.
Bakhshoodeh, R., and Santos, R.M. (2022) Comparative bibliometric trends of microplastics and perfluoroalkyl and polyfluoroalkyl substances: how these hot environmental remediation research topics developed over time. RSC Advances 12, 4973-4987.
Bălan, .A., ChanderMathrani, V., Fengmao Guo, D., and Algazi1, A.M. (2021) Regulating PFAS as a Chemical Class under the California Safer Consumer Products Program. Environ. Health Perspect, 129 (20) February 025001, 1-9.
Blum, A., Balan, S.A., Scheringer, M., Trier, X., Goldenman, G., Cousins, I.T., Diamond, M., Fletcher, T., Higgins, C.P., Lindeman, A.E., Peaslee, G., de Voogt, P., Wang, Z., and Weber, R. (2015) The Madrid Statement on Poly- and Perfluoroalkyl Substances (PFASs). Environ. Health Perspect. 123 (5) May A107-A11.
Cousins, I.T., Johansson, J.H., Salter, M.E., Sha, B. and Scheringer, M. (2022) Outside the Safe Operating Space of a New Planetary Boundary for Per- and Polyfluoroalkyl Substances (PFAS). Environ. Sci. Technol. 2022, 56, 11172−11179.
European Food Standards Agency (EFSA) (2018) Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food. EFSA Journal 16(12), 5194.
European Food Standards Agency (EFSA) (2020) Risk to human health related to the presence of perfluoroalkyl substances in food. EFSA Journal 18(9), 6223.
Felizeter, S., McLachlan, M.S., and de Voogt, P. (2014) Root uptake and translocation of perfluorinated alkyl acids by three hydroponically grown crops. J. Agric. Food Chem. 62 (15), 3334-42.
Figuiére, R., Borchert, F., Cousins, I.T., and Ågerstrand, M. (2023) The essential-use concept: a valuable tool to guide decision-making on applications for authorization under REACH? Environmental Sciences Europe 35 (5) 1-12.
Giesy, J.P., and Kannan, K. (2001) Global Distribution of Perfluorooctane Sulfonate in Wildlife. Environ. Sci. Technol. 35(7) 1339-1342.
Grandjean, P., Andersen, E.W., Budtz-Jørgensen, E., Nielsen, F., Mølbak, K., Weihe, P., and Heilmann, C. (2012) Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA 307(4), 391-7.
Guy, W.S., Taves, D.R., Brey, W.S. (1976) Fluorocompounds in Human Plasma: Prevalence and Characterization. Biochemistry Involving Carbon-Fluorine Bonds, ACS Symposium. 117-134
Hansen, K.J., Clemen, L.A., Eellefson, M.E., and Johnson, H.O. (2001) Compound-specific quantitative characterization of organic fluorochemicals in biological matrices. Environ. Sci. Technol. 35(4) 766-770.
Hansen K.J., Johnson, H.O., Eldridge, J.S., Butenhoff, J.L., and Dick, L.A. (2002) Quantitative Characterization of Trace Levels of PFOS and PFOA in the Tennessee River. Environ. Sci. Technol. 36(8) 1681-1685.
Kwiatkowski, C.F., Andrews, D.Q., Birnbaum, L.S., Bruton, T.A., DeWitt, J.C., Knappe, D.R.U., Maffini, M.V., Miller, M.F., Pelch, K.E., Reade,A., Soehl, A., Trier, X., Venier, M., Wagner, C.C., Wang, Z., and Blum, A. (2020) Scientific Basis for Managing PFAS as a Chemical Class. Environ. Sci. Technol., 7, 532−543.
Lerner, S. (2018)] 3M knew about the Dangers of PFOS and PFOA Decades Ago, Internal Documents Show. The Intercept July 18 2018.
Li, J., Sun, J., and Li, P. (2022) Exposure routes, bioaccumulation and toxic effects of per- and polyfluoroalkyl substances (PFASs) on plants: A critical review,. Environ. International 158, 106891.
Moody, C.A., and Field, J.A. (2000) Perfluorinated Surfactants and the Environmental Implications of Their Use in Fire-Fighting Foams. Environ, Sci. Technol. 34(18), 3864-3869.
Mühle, J., Ganesan, A.L. , Miller, B.R, Salameh, P.K., Harth, C.M., Greally, B.R.,, Rigby, M., Porter, L.W., Steele, L.P., Trudinger, C.M.,, Krummel, P.B., O’Doherty, S.,, Fraser, P.J., Simmonds, P.G., Prinn, R.G.,, and Weiss, R.F.. (2010) Perfluorocarbons in the global atmosphere: tetra-fluoromethane, hexafluoroethane, and octafluoropropane. Atmos. Chem. Phys. 10, 5145–5164.
Preston, B.A. (2017) The Judicial Development of the Precautionary Principle. Queenslnad Government Environmental Management of Firefighting Foam Policy Implementation Seminar, Brisbane 21 Febraury 2017. pp. pp.1`-26. < https://lec.nsw.gov.au >.
Rio Convention (1992) UN Conference on Environment and Development, Rio de Janiero, Brazil, 3-14 June 1992.
Roy, M.A., Cousins, I.T., Harriman, H., Scheringer, M., Tickner. J.A., and Wang, Z. (2022) Combined Application of the Essential-Use and Functional Substitution Concepts: Accelerating Safer Alternatives Environ. Sci. Technol. 56, 9842−9846.
Scheringer, M., Trier, X., Cousins, I.T., de Voogt, P., Fletcher, T., Wang, Z., and Webster, T.F. (2014) Helsingør Statement on poly- and perfluorinated alkyl substances (PFASs). Chemosphere 114 (2014) 337–339.
Schultz, M.M., Barofsky, D.F., and Field, J.A. (2004) Quantitative Determination of Fluorotelomer Sulfonates in Groundwater by LC MS/MS. Environ. Sci. Technol. 38 (6) 1828-1835.
Sonne, C., Desforges, J.-P., Bossi, R., and Long, M. (2023) Assessment of Exposure to Perfluorinated Industrial Substances and Risk of Immune Suppression in Greenland and its Global Context: a Mixed-Methods Study. Lancet Planetary Health 7 (7), E570-E579, July 2023.
Swanson, L. (2019) Testimony of Lori Swanson Former Minnesota Attorney General before the Committee on Oversight and Reform Subcommittee on Environment United States House of Representatives. September 10, 2019. pp. 1-66.
Taves, D.R. (1966) Normal human serum fluoride concentrations. Nature 211, 192-193.
Taves, D.R. (1968) Evidence that there are Two Forms of Fluoride in Human Serum. Nature 217, 1050-1051.
Wang, W., Rhodes, G., YU, X., and Li, H. (2020) Uptake and accumulation of per- and polyfluoroalkyl substances in plants. Chemosphere 261, 127584.
Wilson, S., Fuglestad, J., Larsen, J.-R., Pawlak, J., and Utne, I. (2017) (AMAP Secretariat). Chemicals of Emerging Arctic Concern. Arctic Monitoring and Assessment Programme (AMAP), Oslo, Norway. xvi+353pp.
Yoo, H., Washington, J.W., Jenkins, T.M., and Ellington, J.J. (2011) Quantitative determination of perfluorochemicals and fluorotelomer alcohols in plants from biosolid-amended fields using LC/MS/MS and GC/MS. Environ. Sci. Technol. 45(19), 7985-90.